History of Trade Registry

All information in our history is compiled from trade registry newspapers. Our trade registry number is 265740-0 and we are registered with Istanbul Trade Registry Directorate.

  • 1990

    GBL Gül Biology Laboratuvarı San. ve Tic. Ltd. Şti. was established on 31.05.1990 by Dr. Sait Hulusi Özbudun and Dr. Mehmet Turhan Hacıhasanoğlu as Gül Özel Sağlık ve Eğitim Hizmetleri San. ve Tic. Ltd. Şti. (Dudullu Dispensary) to provide preventive, diagnostic and therapeutic health services..

  • 1993

    Dr. Mehmet Turhan Hacıhasanoğlu transferred his shares to Ms. Gülhan Özbudun, a retired French teacher and wife of Dr. Sait Hulusi Özbudun.

  • 1995

    "Dudullu Dispensary" transformed its main field of activity and income source to "research, development, production, marketing and sales of IVD (In-Vitro Diagnostic) products".

  • 1997

    51% of the company was registered to Dr. Sait Hulusi Özbudun and 49% to Ms. Gülhan Özbudun.

  • 1998

    Mr. Dr. Sait Hulusi Özbudun, who was elected as the company manager in 1998, actively continued his duty as the company manager until 01.05.2011, the date of his death; he personally worked as the most effective creative person in all processes from research and development to production of every product produced by GBL Gül Biology Laboratory, from the installation of quality management systems to the writing of all relevant technical and administrative documents of each product.

  • 2001





    Due to increasing capacity needs, customer conditions and demands, and regulatory requirements, we moved to "İMES Sanayi Sitesi C Blok 305 Sokak No: 16 Dudullu Ümraniye", where we are currently continuing our activities.

    In the same year, the title of our company was changed to GBL Gül Biology Laboratuvarı San. ve Tic. Ltd. Şti. In addition, "R&D, production, marketing and sales of MD (Medical Device) products as well as IVD products" was added to the field of activity. Our company continues its commercial life actively in all product groups written in its current field of activity.

    After the 2001 financial crisis, GBL Gül Biology Laboratory decided to invest again in the same field as a reflection of its horizon for the future of domestic IVD and MD products manufacturing in Turkey, increased its existing capital to 500.000,00 TL in the new currency and allocated most of the increased capital to machinery investment and modernization.
  • .

  • 2003

    All necessary legal licenses, certificates and permits were obtained for our company and our products, and you can access the relevant documents from our certificates.

  • 2010

    Mustafa Çetin Özbudun, son of Dr. Sait Hulusi Özbudun, was appointed as Co-Manager of the company for a period of 10 years by the decision of the Board of Shareholders.

  • 2011

    Dr. Sait Hulusi Özbudun, co-founder of GBL Gül Biology Laboratory, passed away on 01.05.2011. We cannot thank him enough for his efforts in every product, document and license of GBL Gül Biology Laboratory. Her belief in local production and her broad vision will always guide us.

    The shareholding structure of the company has changed as Ms. Gülhan Özbudun (61.50%), Ms. Arzu Özbudun (19.25%) and Mr. Mustafa Çetin Özbudun (19.25%) .

  • 2019

    We opened our branch office at Hattat Sokak No: 10 Şerifali Umraniye, which houses the production of laboratory diagnostic products and management offices. Thus, our manufacturing facilities were divided into 2: disinfectants production in Dudullu OSB Umraniye and laboratory diagnostic products production in Şerifali Umraniye.

  • 2020

    We updated the purpose and subject of our company in order to fully comply with the current IVDR, MDR, Biocidal Products legislation..

  • 2021

    Gülhan Özbudun (Link to 1.h “Our Founders” page), one of the founders of our company and our major partner, retired teacher, who gave our company its name, left the partnership by transferring her shares to Mrs. Arzu Özbudun and Mr. Mustafa Çetin Özbudun. We would like to thank her for dedication in the establishment of GBL, the continuous support in difficult times and long years of hard work..

  • 2023

    Transformation from a Limited Company to a Joint Stock Company. In line with our more corporate, transparent, accountable and growth-oriented strategy, we changed the type of our company. We increased our capital to TL 1,000,000.